This retrospective study investigated the presence of human papillomavirus (HPV) in Chinese women with breast cancer, and the correlation between HPV infection and carcinogenesis. Tumour and noncancerous breast tissue samples were obtained from 62 female patients with breast cancer; normal breast tissue samples were obtained from 46 women without breast cancer. HPV DNA was detected by nested polymerase chain reaction using consensus primers; HPV subtypes were determined by reverse dot blot and pyrosequencing analyses. HPV was found in tumour tissue samples from four of the 62 patients (6.5%), while no HPV DNA was detected in either the noncancerous samples from patients with breast cancer or from the normal breast tissue controls. Of the four HPV-positive cases, three were HPV 16 positive (75%) and one was HPV 18 positive (25%). The low frequency of HPV detected in this study suggests that this infection is not a major risk factor in breast cancer development.
Introduction
Breast cancer is one of the most prevalent malignancies affecting women worldwide, with an annual incidence of about 1 million cases. 1, 2 The aetiology of breast cancer remains poorly understood. Many risk factors -including family history, hormone levels, cigarette smoking and alcohol consumption -have been found to be associated with the pathogenesis of this disease. 2 These factors cannot, however, explain all cases of breast cancer, 2 and it has been proposed that viruses such as mouse mammary tumour virus, Epstein-Barr virus and human papillomavirus (HPV) might be associated with the development of breast cancer. 3 − 5 Epidemiological and molecular studies have shown that a persistent infection with high-risk HPV is the most crucial risk factor for cervical cancer. 6 A number of studies have shown that HPV may cause cancer at a X Mou and L Chen contributed equally to this work.
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other sites including the head, neck, anus and colon. 7 − 9 Moreover, it has been reported that HPV 16 and HPV 18 can immortalize normal breast epithelial cells. 10, 11 Unlike cervical cancer, which is almost always correlated with HPV, 6 the role of HPV infection in the development of breast cancer remains controversial.
Di Lonardo et al. 12 first demonstrated the relationship between HPV infection and breast cancer in 1992. Since then, a growing number of studies have reported the detection of HPV DNA in breast cancer tissues, with the prevalence ranging from 0 to 86.2%. 12 -28 The big variation in the prevalence of HPV among various sets of breast cancer samples may be due to differences in study design, the populations involved and the HPV detection techniques used.
Given the controversy regarding the aetiology of HPV in breast cancer, the present study investigated the presence and the genotype of HPV in Chinese patients with breast cancer, and determined the relationship between HPV infection and breast cancer development.
Patients and methods

PATIENTS AND SAMPLE COLLECTION
Clinical samples for this retrospective study were obtained between July 2006 and November 2008 from patients admitted to The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. Samples of tumour tissue and normal breast tissue adjacent to a tumour site were collected from patients with sporadic breast cancer. Breast tissue from women without breast cancer was collected from patients with breast tenderness who attended the Surgical Department of The First Affiliated Hospital, Zhejiang University School of Medicine: these served as negative controls.
None of the cases or controls had a previous history of cervical cancer or dysplasia, or clinical evidence of HPV infection in the body.
Tissue samples were divided into two parts: one was used for histopathological examination and the other was immediately frozen and stored in liquid nitrogen for DNA analysis. Breast cancer tissue samples were classified using the tumour, node, metastasis classification of malignant tumours staging system and were assessed for the presence of oestrogen and progesterone receptors. Information regarding all samples was collected and entered into a sample collection database.
This project was approved by the Ethics Committee of the First Affiliated Hospital, Zhejiang University School of Medicine. All patients provided written informed consent for the use of their clinical samples in this study.
DNA PREPARATION
The DNA isolation was carried out as described previously. 8 Briefly, about 50 mg of each tissue sample was homogenized in 6.7 mM phosphate-buffered saline, pH 7.2, using an electric homogenizer (PRO Scientific, Oxford, CT, USA). DNA was extracted using the MasterPure™ DNA Purification Kit (Epicentre Biotechnologies, Madison, WI, USA) according to the manufacturer's instructions. To avoid cross contamination, a maximum of 10 tissue samples were processed per day. The quality of the DNA extracted was checked by polymerase chain reaction (PCR) with glyceraldehyde phosphate dehydrogenase (GAPDH) primers (forward, 5'-TTGCCATCA ATGACCCCTTCA-3'; reverse, 5'-ACTCACTC CTGGAAGATGGTG-3').
HPV DNA DETECTION AND GENOTYPING
The PCR was used to amplify HPV DNA using X Mou, L Chen, F Liu et al. Low HPV prevalence in breast cancer PGMY09/11 consensus primers for the HPVL1 gene, as described previously. 29 These PCR products served as templates for a nested PCR reaction with the internal consensus primer set GP5 + /6 + . 30 Water was used in place of sample DNA for the first-run PCR and for the nested PCR as a negative control. If any of the controls showed a false-positive result, the whole set of PCR and nested PCR reactions were restarted with new reagents.
Results were visualized by electrophoresis of 3 µl of nested PCR product on a 1% agarose gel, and staining with ethidium bromide.
Positive samples were genotyped by reverse dot blot analysis using the HPV GenoArray Test Kit (Hybribio Ltd, Hong Kong). Probes for HPV subtypes 6, 11, 42, 43, 44, 16, 18, 31, 33, 35, 39, 45 , 51, 52, 53, 56, 58, 59, 66, 68 and CP8304 were used, as well as a biotin and positive control. Positive PCR products were further validated by pyrosequencing. 31 The individual viral sequence was then analysed using the Basic Local Alignment Search Tool (BLAST) at the National Center for Biotechnology Information (Bethesda, MD, USA).
STATISTICAL ANALYSES
Statistical analyses were carried out using the R statistical software (version 2.10.1, www.r-project.org). Statistical significance was determined by use of Fisher's exact test or the Wilcoxon rank-sum test at a level of P = 0.05. Table 1 .
Results
Samples
Extracted DNA from the 62 tumour samples, the 62 samples of tissue adjacent to the tumour and the 46 normal breast tissue samples were checked by PCR. All samples were shown to be positive for GAPDH, indicating adequate quality of the specimens. The non-template negative control revealed no evidence of reagent contamination.
Using the HPV L1 consensus primer sets, HPV DNA was detected in four of the 62 tumour tissue samples (6.5%). No significant correlation was found between the presence of HPV and patient age, tumour size, metastasis or tumour marker (oestrogen receptor or progesterone receptor; data not shown). HPV in the tumour tissue did not appear to be related to the aggressiveness of the breast cancer. Tissue samples from adjacent to the tumour sites and normal breast tissue samples from the control group all tested negative for HPV DNA.
Genotypes of HPV in the positive samples were determined by reverse dot blot analyses. Of the four HPV positive samples, three were HPV 16 positive, and one was HPV 18 positive ( Figs 1A and 1B) . Pyrosequencing results were consistent with those found by reverse dot blot analyses (Fig. 1C ).
Discussion
Breast cancer is one of the most common malignancies worldwide. 1, 2 Although China has a low morbidity rate from breast cancer, the yearly incidence rate of this disease in China is increasing. China has the largest global population and, as a result, it has the highest number of breast cancer cases. Despite this, general medical care for patients with breast cancer lags behind developed countries.
The development of breast cancer is known to be a multifactorial process, but the aetiology remains unclear. Previous studies have revealed that viral infection may play a key role in breast cancer development. 3 − 5 Identification of an infectious aetiology could improve the current understanding of this disease and open new possibilities for its diagnosis, treatment and prevention.
A number of studies have been performed to determine whether HPV is present in breast cancer tissue ( Table 2 ). 12 -28 The detection rates for HPV infection reported in these studies vary dramatically between 0 and 86.2%. There may be several possible reasons for the highly inconsistent results among the studies, including the sensitivity of the assays used for HPV detection. Primer sets that amplify different HPV regions could result in different detection rates. 12, 19, 24 Furthermore, HPV viral load may be very low in breast tissue compared with cervical cancer tissue, 32 which could affect the detection of HPV in breast tissue. To address these potential problems, the present study used a detection method that has been validated and proven to be highly sensitive in previous studies. 8, 29 Contamination could also affect detection rates. The HPV template could be introduced accidentally into the tumour samples during sample collection, DNA isolation or PCR amplification, resulting in false positives. It has been suggested that HPV detection rates are significantly higher when DNA is extracted from paraffin-embedded tissues compared with fresh tissues, further indicating that biopsy-taking and slide preparation may affect detection rates. 5 Thus, in the present study, fresh tissues were carefully collected by surgeons according to a standardized protocol, using a new blade for dissecting each sample to avoid crosscontamination. Unlike previous studies, 12, 16, 24 the present study also included non-template (water) controls, the lack of which could also X Mou, L Chen, F Liu et al. The rate of HPV infection in breast cancer patients may vary among different populations ( Table 2 ). 12 -28 The age, region and lifestyle of the selected population could all contribute to the HPV infection rate. Indeed, there may be a higher prevalence in young women that decreases with advancing age. 33 Thus, age could be one of the reasons for the low HPV detection rate in the present study, where the mean age was 53.79 years. Europe has been reported to have the lowest HPV prevalence, while Oceania, followed by Asia, has the highest. 5 Although the present study population was Asian, the HPV infection rate was lower than that described previously. 25, 34 This reveals the complex relationship between HPV infection, the population, genomic heterogeneity and cancer. Kroupis et al. 21 reported that HPV infection was associated with pathological characteristics in breast cancer. No such correlation was observed in the present study. Widschwendter et al. 26 showed a high prevalence of HPV infection in breast cancer patients with a history of cervical cancer, indicating that HPV DNA may be transported from the original site of infection. The present study only included patients without evidence of previous HPV infection, which could be another reason for the low HPV detection rate in the patient group.
Low HPV prevalence in breast cancer
It has been suggested that the high-risk subtypes of HPV for breast cancer are probably different from the high-risk subtypes of HPV for cervical cancer. 6 Several studies have found that HPV 33 is the most common subtype found in breast cancer patients, especially in Asian patients. 17, 32, 35 HPV 16 was the most common subtype in the present study (three out of four HPV-positive samples). This finding, combined with those of other studies, 12, 19, 26 suggests that HPV 16 and HPV 18 are the most prevalent subtypes in breast cancer, although the overall HPV detection rate in the present study was low.
In conclusion, the frequency of HPV DNA seems to be low in breast cancer, and the results of the present study do not support the hypothesis that HPV may play a major role in breast cancer development. More studies are needed to determine the association between HPV infection and breast cancer.
